Patent ID: 8901155

Claim:
A method for treating a TRPV1-mediated disease, comprising administering to a patient a therapeutically effective amount of a compound, or a salt thereof, represented by the following formula [I]: wherein A represents a lower alkylene group or a lower alkenylene group; R 1 represents a hydrogen atom, an unsubstituted or substituted alkyl group or an unsubstituted or substituted alkenyl group; and R 2 and R 3 are the same or different and represent a hydrogen atom, an unsubstituted lower alkyl group or a lower alkyl group substituted by a monocyclic cycloalkyl group, a polycyclic cycloalkyl group or an aryl group, wherein the TRPV1-mediated disease is selected from the group consisting of pain, an overactive bladder and a gastrointestinal dysfunction.